You are viewing a limited version of this profile. To access i3's full capabilities.
Clear Labs
Save
Company logo (jpg or png)
Parent company

Short description

Developer of technologies and methods for rapidly analyzing and indexing foods

Founded in 2014
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector food supply chain

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Menlo Park, CA Menlo Park, United States
Address
City
State
Zip
Country

Parent Companies

Updated by Jonathan Koch at on 08/16/2017

Edited by Cleantech Group on 06/30/2021

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
03/25/2019
Oxford Nanopore Technologies Oxford Nanopore Technologies
Clear Labs is partnering with Oxford Nanopore to provide rapid testing in food manufacturing for pathogens such as salmonella. Clear Labs’ flagship product Clear Safety will leverage Oxford Nanopore’s GridION DNA sequencing technology.
View source    
Confirmed by Oxford Nanopore Technologies
Development Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
05/26/2021 Counterpoint Investors Counterpoint Investors , T. Rowe Price T. Rowe Price , Redmile Group Redmile Group , Menlo Ventures Menlo Ventures , Wing Venture Capital Wing Venture Capital , GV GV , HBM Genomics HBM Genomics , Khosla Ventures Khosla Ventures , Felicis Ventures Felicis Ventures , Dafgard Dafgard (10)
Post-money valuation of
The proceeds will help advance Clear Labs’ turnkey solutions for real-time genomic analysis of the virus, designed for public health organizations, reference labs, hospitals and epidemiologists.
Growth Equity $60,000,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font